Neurodevelopmental outcomes at 2 and 4 years in children with congenital heart disease.

Cheryl L BrosigLaurel BearSydney AllenPippa SimpsonLiyun ZhangMichele FrommeltKathleen A Mussatto

Published in: Congenital heart disease (2018)

Despite significant correlations between 2- and 4-year-old test scores, many patients who scored in the average range at age 2 showed deficits at age 4. BSID-III scores at age 2 may underestimate delays. Therefore, longitudinal ND assessment is recommended.

Keyphrases

traumatic brain injury
young adults
type diabetes
cross sectional
glycemic control
clinical evaluation